AMA honors former Maine state rep with Government Service Award
At the National Advocacy Conference, the AMA presented former Maine State Rep. Richard A. Evans, M.D., with the AMA Award for Outstanding Government Service.
AMA applauds rule removing barriers to care for opioid use disorder
The final rule by the Department of Health and Human Services makes permanent changes to opioid use disorder medication prescribing.
Add flexibility on buprenorphine Rx for opioid-use disorder
Nation’s worsening opioid-overdose epidemic prompts AMA call to eliminate buprenorphine dose limits to provide adequate treatment. Learn more.
Jan. 26, 2024: National Advocacy Update
Bipartisan Substance Use Disorder Workforce Act reintroduced in the House and more in the latest National Advocacy Update.
Meet new DEA training requirement
Satisfy the new eight-hour MATE Act training requirement on treating patients with opioid or other substance use disorders with CME from AMA Ed Hub™.
Dec. 15, 2023: State Advocacy Update
Massachusetts launches statewide effort to remove stigmatizing questions from credentialing processes and more in the latest State Advocacy Update.
Why we must act quickly and decisively to end the overdose epidemic
The nation’s drug-related overdose and death epidemic demands immediate and collective action, with physicians taking the lead.
The nation’s overdose epidemic is growing in complexity
Over 107,000 Americans died of a drug-related overdose last year, but payers have yet to step up to boost access to lifesaving treatment.
AMA Advocacy Insights webinar series: Strategies to address the drug overdose and death epidemic
Learn about the nation’s drug overdose and death epidemic, and the efforts made by physicians to end the epidemic in this AMA Advocacy Insights webinar.